Clinical Trials Arena on MSN
Gilead and Arcus reignite anti-TIGIT interest with Phase II gastric cancer win
During the Phase II EDGE-Gastric study (NCT05329766), the Fc-silent anti-T cell immunoreceptor with immunoglobulin and ITIM ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results